Search filters

List of works by Russell Madison

Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study

scientific article published on 24 December 2019

Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors

scientific article published on 17 April 2020

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

scientific article published on 20 October 2018

Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer

scientific article published on 09 June 2020

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

correction of a scholarly article

TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations

scientific article published on 15 August 2019

Targetable gene fusions and aberrations in genitourinary oncology

scientific article published on 12 October 2020

The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA

scientific article published on 11 October 2019

US phase 1 first-in-human study of taletrectinib (DS-6051b/AB-106), a ROS1/TRK inhibitor, in patients with advanced solid tumors

scientific article published on 26 June 2020

Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study

scientific article published on 08 February 2020

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

scientific article published on 08 November 2019

Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions

scientific article published on 27 January 2020

Paulina is supported by:

About Paulina

Help